 hyperlipidemia nephrot syndrom lipid abnorm patient nephrot syndrom signific lipid abnorm mechan potenti treatment caus debat recent data area controversi studi lipoprotein abnorm patient uncompl nephrot syndrom mani level total low-dens lipoprotein cholesterol level high-dens lipoprotein cholesterol lipid abnorm signific popul popul patient unremit nephrot syndrom high risk cardiovascular diseas elev cholesterol level nephrot syndrom enhanc hepat synthesi contribut decreas clearanc enzym activ signal enhanc hepat lipogenesi chang plasma albumin concentr plasma oncot pressur local effect viscos hepat sinusoid level loss urinari protein liporegulatori substanc number short-term studi nephrot patient safeti efficaci lipid-low drug bile acid-bind resin probucol hmgcoa hydroxymethylglutaryl reductas inhibitor